TNFSF15 and asthma: Taken together with our data, which shows that blocking TL1A reduces collagen deposition and smooth muscle hypertrophy [(Figure 2C and (19)], targeting TL1A appears to be a novel approach to treat all features of airway inflammation and remodeling associated with asthma.